Stocks to Watch Today, 15th April 2025: Reliance Ind., HCL Tech, Zydus Lifesciences, Ashoka Buildcon, and more

Indian benchmark stocks, the Sensex and the Nifty 50, are expected to start trading on a positive note on Tuesday, 15th April 2025. This positive sentiment is driven by a wider rally seen in international markets, creating a good backdrop for local equities. Shareholders will be closely watching a combination of company-specific news and information that is likely to dictate trading activity during the session.

Key Stocks in Focus

Reliance Industries reported that its wholly owned step-down subsidiary Nauyaan Tradings has raised its equity holding in Nauyaan Shipyard by buying an additional 10% from Welspun Corp for ₹51.72 crore. Even after this deal, Nauyaan Shipyard will remain a step-down subsidiary of Reliance Industries.

Tata Power Renewable Energy, a group company of Tata Power, has signed a power purchase agreement (PPA) with NTPC to develop a 200 MW Firm and Dispatchable Renewable Energy Project. This project is valued at an estimated ₹4,500 crore and is expected to be completed in a 24-month horizon. This is adding Tata Power Renewable Energy's overall renewable utility capacity to 10.9 GW. The project will produce around 1,300 million units of electricity every year.

Godrej Industries' Chemical Business has finalized the acquisition of the food additives business of Savannah Surfactants. The plant in Goa of Savannah has a production capacity of 5,200 metric tonnes of finished goods per annum. This acquisition is likely to strengthen Godrej's chemicals business by diversifying its product base for the global food and beverage industry.

HCL Technologies has made strategic integrations to help speed up the adoption of Artificial Intelligence (AI) in enterprises. The company has integrated NVIDIA AI Enterprise into its GenAI-driven service platform, AI Force, and NVIDIA Omniverse with its physical AI solution, SmartTwin. These integrations are meant to streamline software development processes and boost engineering productivity.

Zydus Lifesciences has obtained final approval from the United States Food and Drug Administration (US FDA) for the production of Jaythari (Deflazacort) Tablets in different strengths. This drug is used in the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients aged five years and older.

Dr. Reddy's Laboratories has denied some recent reports quoting a 25% cutback in its manpower, explaining that such rumors have no basis and that its operation is business as usual.

Sula Vineyards posted a revenue of ₹618.8 crore in FY 2025, up from the last FY by 1.7%.

Ashoka Buildcon is the lowest bidder for a ₹568.86 crore gauge conversion work by Central Railway, which includes earthwork, bridges, and civil works over a 53.3 km section with an estimated time of completion within 30 months.

Delhivery: Sahil Barua, the promoter of logistics company Delhivery, has resigned as an Independent Director on the board of food delivery platform Swiggy citing added work pressures.

Bajaj Housing Finance: The lock-in period of shareholders for a percentage of Bajaj Housing Finance shares is also ending today, which could result in higher trading volumes.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.